Clinical Trials on Extensive-stage Small-cell Lung Cancer in Japan
Total 395 results
-
Wakayama Medical UniversityMerck Sharp & Dohme LLCUnknownSmall Cell Lung Cancer Extensive StageJapan
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer Stage II | Non-small Cell Lung Cancer Stage IB | Non-small Cell Lung Cancer Stage ⅢAJapan
-
Bristol-Myers SquibbRecruitingExtensive-stage Small Cell Lung CancerNetherlands, Belgium, United States, Australia, Greece, Italy, Canada, Japan, Poland, Romania, Spain
-
AmgenRecruitingExtensive Stage Small Cell Lung CancerKorea, Republic of, United States, Netherlands, Taiwan, Switzerland, Spain, Canada, Israel, Germany, France, Belgium, Australia, Japan, Italy, Denmark
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingExtensive-stage Small-cell Lung CancerUnited States, Korea, Republic of, Spain, Taiwan, France, Japan, Germany, China, Austria
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedNon-small Cell Lung Cancer | Extensive Disease Small Cell Lung CancerJapan
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedNon-small Cell Lung Cancer | Extensive Disease Small Cell Lung CancerJapan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Limited Stage Lung Small Cell Carcinoma | Stage I Lung Cancer AJCC v8United States, Japan
-
Tomoshi TsuchiyaCompleted
-
Hamamatsu UniversityCompletedNon-small Cell Lung CancerJapan
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaboratorsUnknownNon-small- Cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.TerminatedNon-small-cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedStage IV Non-Small Cell Lung CancerSpain, United States, France, Japan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Samsung Bioepis Co., Ltd.RecruitingNon-small Cell Lung Cancer Stage IVGeorgia, India, Romania, Spain, Germany, Japan
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)Japan
-
Shiga UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study GroupActive, not recruitingNon-squamous Non-small-cell Lung Cancer | Cancer, LungJapan
-
Kobe City General HospitalTerminatedAdvanced Non-small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Novartis PharmaceuticalsCompleted
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon Small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.Completed
-
R-PharmCompletedNon-small Cell Lung Cancer (NSCLC)Japan
-
Sumitomo Pharma Co., Ltd.TerminatedSmall-cell Lung CancerJapan
-
Eisai Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, JapanUnknown
-
Daiichi Sankyo Co., Ltd.CompletedCervical Cancer | Small Cell Lung Cancer | Ovarian Cancer | Non-small Cell Lung Cancer | Gastric Cancer (Inoperable and Recurrent)Japan
-
AmgenRecruitingSmall Cell Lung Cancer | Limited Stage Small Cell Lung CancerChina, Japan, Taiwan, Australia, Turkey, United States, Korea, Republic of
-
Hamamatsu UniversityCompletedNon-Small Cell Lung CancerJapan
-
Astellas Pharma Global Development, Inc.Terminated
-
Daiichi Sankyo Co., Ltd.TerminatedNon Small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-Small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedSmall Cell Lung CancerJapan
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerJapan
-
AstraZenecaActive, not recruitingSmall Cell Lung Carcinoma Extensive DiseaseGermany, United States, Poland, Taiwan, Turkey, Italy, Korea, Republic of, Brazil, Czechia, Hungary, Japan, Russian Federation, China, Netherlands, Spain, Israel, Ukraine, Austria, France, Bulgaria, Romania, Argentina, Slovakia
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer (Stage III)United States, Spain, Taiwan, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Russian Federation, China, Malaysia, Argentina
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Gunma UniversityJ~pharmaCompletedNon-Small Cell Lung Cancer | AngiogenesisJapan
-
Bristol-Myers SquibbOno Pharma USA IncCompleted
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerJapan